title: Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.
authors: L B S
authors: LB
authors: Gelinck
authors: Y K O
authors: YK
authors: Teng
authors: G F
authors: GF
authors: Rimmelzwaan
authors: B J F
authors: BJ
authors: van den Bemt
authors: F P
authors: FP
authors: Kroon
authors: J M
authors: JM
authors: van Laar
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology*; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007252:Influenza Vaccines; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab